...to diagnose and prognose the invasiveness of tumors. The DMTXinvaScan uses a mAb developed by Oncomatrix...
...and its encoded protein, which are expressed in the stroma fibroblasts associated with invasive tumors. Oncomatrix S.L....

...while Oncomatrix will generate corresponding immunotoxins and conduct in vivo testing and Phase I development. Oncomatrix...
...rights to IP resulting from the deal, while the university will be eligible for royalties. Oncomatrix S.L....